Methaqualone

This classification denotes a sedative and hypnotic with the molecular formula C16H14N2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7ZKH8MQW6T, chemically known as 3,4-dihydro-2-methyl-4-oxo-3-o-tolylquinazoline but generally known as methaqualone, which bears US NIH Compound Identifier 6292. European Medicines Agency schedules Methaqualone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08840MIG. The term METHAQUALONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 16, No. 3 1962, List 4). World Health Organization schedules methaqualone in its Anatomical Therapeutic Chemical (ATC) Classification. METHAQUALONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule methaqualone under HS 29335500 and SITC 51576. As of Q4 2014, METHAQUALONE remains the US FDA Preferred Term for this commodity. Methaqualone bears US NLM identifiers UMLS ID C0025627 and NCI Concept Code C640. SMILES: O=C1N(C2C(CCCC2)C)C(NC2C1CCCC2)C.